Bookmarks
ILARThe International League of Associations for Rheumatology’s mission is to advance rheumatology in developing countries. The ILAR Executive Committee consists of the Presidents and Presidents-Elect of ACR, EULAR, PANLAR, APLAR and AFLAR. The collaboration of the leaders of these international organizations has resulted in a renewed commitment to provide grants to support programs that lead to progress in the practice and education of rheumatology in countries where there is an exceptional need.
Saved once
(save)
Bookmarked by gracedrury on 27 Apr 2017
|
The global burden of other musculoskeletal disorders: estimates from the Global Burden of Disease 2010 study
by Global MusculoskeletalObjective: To estimate disability from the remainder of musculoskeletal (MSK) disorders (categorised as other MSK) not covered by the estimates made specifically for osteoarthritis (OA), rheumatoid arthritis (RA), gout, low back pain and neck pain, as part of the Global Burden of Disease (GBD) 2010 study.
The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study
by Global MusculoskeletalObjective: To estimate the global burden of hip and knee osteoarthritis (OA) as part of the Global Burden of Disease 2010 study and to explore how the burden of hip and knee OA compares with other conditions.
The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study
by Global MusculoskeletalObjectives: To estimate the global burden of rheumatoid arthritis (RA), as part of the Global Burden of Disease 2010 study of 291 conditions and how the burden of RA compares with other conditions.
The global burden of musculoskeletal conditions for 2010: an overview of methods
by Global MusculoskeletalThe objective of this paper is to provide an overview of methods used for estimating the burden from musculoskeletal (MSK) conditions in the Global Burden of Diseases 2010 study. It should be read in conjunction with the disease-specific MSK papers published in Annals of Rheumatic Diseases.
Epidemiology: Measurement matters—making musculoskeletal disease count
by Global MusculoskeletalReliable estimates of disease burden support rational allocation of financial and human resources. Measurement is a powerful force for change as 'what gets measured gets done'. The global burden of musculoskeletal disease studies ensures visibility of these highly prevalent, disabling diseases. Now we must act to reduce disease burden.